Annual direct medical cost of active systemic lupus erythematosus in five European countries

Rituximab — Shadow, illusion or light?

(2011) Ronald F. van Vollenhoven   AUTOIMMUNITY REVIEWS

Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report

(2011) M Aringer et al.   LUPUS

A structured literature review of the direct costs of adult systemic lupus erythematosus in the US

(2011) Katherine A. Slawsky et al.   ARTHRITIS CARE & RESEARCH

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

(2010) G. K. Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

SLE diagnosis and treatment: When early is early

(2010) Andrea Doria et al.   AUTOIMMUNITY REVIEWS

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database

(2010) Elise M. Pelletier et al.   CLINICAL THERAPEUTICS

Healthcare Cost and Loss of Productivity in a Canadian Population of Patients with and without Lupus Nephritis

(2010) E. AGHDASSI et al.   JOURNAL OF RHEUMATOLOGY

Cost-of-illness studies in systemic lupus erythematosus: A systematic review

(2010) Tracy Y. Zhu et al.   ARTHRITIS CARE & RESEARCH

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

(2009) M. Mosca et al.   ANNALS OF THE RHEUMATIC DISEASES

The impact of flare on disease costs of patients with systemic lupus erythematosus

(2009) Tracy Y. Zhu et al.   ARTHRITIS AND RHEUMATISM

Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five-year analysis of a large medicaid population

(2009) Tracy Li et al.   ARTHRITIS AND RHEUMATISM

Direct and Indirect Costs to Employers of Patients With Systemic Lupus Erythematosus With and Without Nephritis

(2009) Ginger Carls et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

The socioeconomic burden of SLE

(2009) Chak Sing Lau et al.   Nature Reviews Rheumatology

Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong

(2009) T. Y. Zhu et al.   RHEUMATOLOGY

Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus

(2008) Pantelis Panopalis et al.   ARTHRITIS AND RHEUMATISM